Not investment advice. FilingSight is an automated analytical research tool, not a registered investment advisor. Ratings and scores are quantitative analytical classifications, not buy or sell recommendations. Nothing here is personalized to your circumstances. Investing involves risk of loss — consult a licensed professional. See full disclosures.
CME Group Inc.
CMEFinancialsGenerated Jul 5, 2026, 08:13 PM UTC
CME (CME Group Inc.) analytical snapshot. Revenue grew +11.1% YoY to $5.58B. 5-year revenue CAGR +2.8%; 10y CAGR +6.7%. Net margin at 37.75% (contracting ▼). Market cap $15.77B at $236.60 per share. Trailing P/E 26.70, P/S 2.83, P/B 0.59. EV/Operating income ≈ 3.89 (EV $13.38B). Risk: Elevated. Macro: Risk-on · Supportive. Composite analytical score 6 (data confidence 81%). Descriptive analytics from public filings — not investment advice.
Free SEC analysis
— computed from SEC filings, free to readFundamentals
Revenue grew +11.1% YoY to $5.58B. 5-year revenue CAGR +2.8%; 10y CAGR +6.7%. Net margin at 37.75% (contracting ▼).
- Revenue grew +11.1% YoY to $5.58B.
- 5-year revenue CAGR +2.8%; 10y CAGR +6.7%.
- Net margin at 37.75% (contracting ▼).
- Return on equity 7.95%, ROA 1.53%, ROIC 12.97%.
- Gross margin 0.00%, operating margin 61.58%.
- Free cash flow margin 60.54% ($3.38B).
- Net income down ▼ +34.7% YoY.
- Asset turnover 0.03 — capital efficiency.
| FY | Revenue | Rev YoY | Gross% | Op% | Net% | FCF | ROE% |
|---|---|---|---|---|---|---|---|
| 2016 | $3.11B | — | 0.00 | 56.82 | 36.21 | $1.15B | 5.48 |
| 2017 | $3.33B | +6.9% | 0.00 | 59.78 | 11.06 | $1.42B | 1.76 |
| 2018 | $3.60B | +8.1% | 0.00 | 61.21 | 42.67 | $1.64B | 7.46 |
| 2019 | $3.64B | +1.4% | 0.00 | 63.40 | 111.49 | $1.67B | 19.98 |
| 2020 | $4.31B | +18.2% | 0.00 | 60.51 | 45.53 | $2.32B | 7.51 |
| 2021 | $4.87B | +13.0% | 0.00 | 53.16 | 43.48 | $2.43B | 8.04 |
| 2022 | $4.88B | +0.3% | 0.00 | 54.01 | 43.11 | $2.52B | 7.68 |
| 2023 | $4.69B | -4.0% | 0.00 | 56.40 | 56.22 | $2.28B | 9.81 |
| 2024 | $5.02B | +7.0% | 0.00 | 60.08 | 64.27 | $2.97B | 12.07 |
| 2025 | $5.58B | +11.1% | 0.00 | 61.58 | 37.75 | $3.38B | 7.95 |
| Quarter end | Revenue | YoY | QoQ | Net margin |
|---|---|---|---|---|
| Mar 31, 2025 | $1.64B | +10.4% | — | — |
| Jun 30, 2025 | $3.33B | +10.4% | +103.0% | — |
| Jun 30, 2025 | $1.69B | -44.0% | -49.3% | — |
| Sep 30, 2025 | $4.87B | +5.8% | +187.9% | — |
| Sep 30, 2025 | $1.54B | -66.6% | -68.4% | — |
| Mar 31, 2026 | $1.88B | +14.5% | +22.3% | — |
Filings & Ownership
Latest annual report (10-K) filed Feb 26, 2026. Latest quarterly report (10-Q) filed Apr 24, 2026. 11 recent 8-K material-event filings in the index.
- Latest annual report (10-K) filed Feb 26, 2026.
- Latest quarterly report (10-Q) filed Apr 24, 2026.
- 11 recent 8-K material-event filings in the index.
- Recent insider Form 4s: 0 buy vs 0 sell transactions.
- ~10,000+ recent 13F-HR filings reference CME Group Inc.; broad institutional reporting.
- Recent filers include MARK MORRIS ET AL, WINNOW WEALTH LLC, Walleye Trading LLC.
- 1 recent 13D activist/beneficial-ownership filings — potential catalyst.
- 19 recent 13G passive institutional ownership notices.
| Filer | Form | Filed |
|---|---|---|
| MARK MORRIS ET AL | 13F-HR | Feb 13, 2008 |
| WINNOW WEALTH LLC | 13F-HR | Aug 21, 2025 |
| Walleye Trading LLC | 13F-HR | Nov 6, 2007 |
| CTC Fund Management LLC | 13F-HR | May 15, 2012 |
| Capital Wealth Planning, LLC | 13F-HR | Aug 13, 2018 |
| Date | Form | Description |
|---|---|---|
| Jun 17, 2026 | 8-K | 8-K |
| Jun 10, 2026 | 8-K | 8-K |
| May 19, 2026 | 8-K | 8-K |
| Apr 27, 2026 | 8-K | 8-K |
| Apr 22, 2026 | 8-K | 8-K |
| Feb 4, 2026 | 8-K | 8-K |
| Feb 2, 2026 | 8-K | 8-K |
| Oct 22, 2025 | 8-K | 8-K |
SEC Filing Deep-Analysis
No significant implicit signals detected. Key metrics are changing within normal ranges.
- Endogenous analysis: No significant implicit signals detected in the latest filing. Key metrics are changing within normal ranges — the filing appears consistent with prior-period patterns.
- 8 new XBRL disclosure(s) in latest filing — expanding reporting scope.
- 20 disclosure(s) dropped from prior year — reduced reporting granularity.
| Metric | Prior year | Latest year | Change | % Change |
|---|---|---|---|---|
| Revenue | $5.02B | $5.58B | $559.5M | +11.1% |
| Operating income | $3.02B | $3.44B | $419.8M | +13.9% |
| Net income | $2.64B | $3.23B | $589.8M | +22.4% |
| Operating cash flow | $3.06B | $3.45B | $397.8M | +13.0% |
| Capex | $89.7M | $76.4M | $-13.3M | -14.8% |
| Total assets | $129.71B | $137.45B | $7.74B | +6.0% |
| Total liabilities | $102.97B | $110.96B | $7.99B | +7.8% |
| Cash & equivalents | $2.72B | $2.91B | $191.9M | +7.1% |
| Stockholders equity | $26.74B | $26.49B | $-251.0M | -0.9% |
| Accounts receivable | $535.6M | $573.1M | $37.5M | +7.0% |
| Type | Concepts |
|---|---|
| Added | ConversionOfStockSharesConverted1, ConvertiblePreferredStockSharesIssuedUponConversion, EquitySecuritiesWithoutReadilyDeterminableFairValueAmount, EquitySecuritiesWithoutReadilyDeterminableFairValueImpairmentLossCumulativeAmount, IncrementalCommonSharesAttributableToConversionOfPreferredStock, NetIncomeLossFromContinuingOperationsAvailableToCommonShareholdersDiluted, OtherInvestmentNotReadilyMarketableFairValue, UndistributedEarningsLossAvailableToCommonShareholdersBasic |
| Removed | AllocatedShareBasedCompensationExpense, AllowanceForDoubtfulAccountsReceivable, CommonStockDividendsPerShareDeclared, ComprehensiveIncomeNetOfTax, CurrentFederalTaxExpenseBenefit, CurrentForeignTaxExpenseBenefit, CurrentIncomeTaxExpenseBenefit, CurrentStateAndLocalTaxExpenseBenefit, DeferredFederalIncomeTaxExpenseBenefit, DeferredForeignIncomeTaxExpenseBenefit |
| Term | Severity | Recent | Prior | Status |
|---|---|---|---|---|
| Restructuring | medium | 57 | 3 | Ongoing |
Unlock the rest
- ProValuationMarket cap $15.77B at $236.60 per share.
- ProPrice & TechnicalsPrice $236.60 — downtrend (below 200-DMA); 1-month momentum negative.
- ProMacro & RatesMarket regime: Risk-on · Supportive.
- ProRisk ScorecardComposite risk: Elevated.
This content is for Pro subscribers
Unlock the full breakdown from all analysts — valuation (DCF & Graham), price & technicals, macro, risk scorecard, and 13F/13D ownership flow — plus your research workspace.
3 sections free · 4 Pro sections locked · composite 6
Macro exposure
Rate-sensitive · High sensitivityMacro regime: Risk-on · Supportive. CME Group Inc. is a rate-sensitive name (high macro sensitivity) — a supportive backdrop, though defensives lag risk-on tapes.
Analytical read
deterministic previewMarket cap $15.77B at $236.60 per share..
Peer comparison
Rate-sensitive groupHow CME stacks up against tracked peers with similar macro sensitivity — by analytical score and macro exposure.
| Company | Score | Macro |
|---|---|---|
| Capital One Financial COF | 23 | Neutral |
| Chubb Ltd. CB | 23 | Neutral |
| U.S. Bancorp USB | 17 | Neutral |
| JPMorgan Chase & Co. JPM | 16 | Neutral |
| Prologis Inc. PLD | 14 | Neutral |
| Simon Property Group SPG | 13 | Neutral |
| American Express Co. AXP | 11 | Neutral |
| Bank of America Corp. BAC | 11 | Neutral |
| Visa Inc. V | 8 | Neutral |
| Mastercard Inc. MA | 8 | Neutral |
| Public Storage PSA | 8 | Neutral |
| Dominion Energy D | 6 | Neutral |
| Charles Schwab Corp. SCHW | 6 | Neutral |
| CME Group Inc. CME● you | 6 | Neutral |
| PNC Financial Services PNC | 4 | Neutral |
| Realty Income Corp. O | 4 | Neutral |
| Travelers Cos. TRV | 2 | Neutral |
| Duke Energy Corp. DUK | 0 | Neutral |
| Bank of New York Mellon BK | 0 | Neutral |
| Marsh & McLennan MMC | 0 | Neutral |
| Equity Residential EQR | 0 | Neutral |
| Wells Fargo & Co. WFC | -1 | Neutral |
| Welltower Inc. WELL | -1 | Neutral |
| Exelon Corp. EXC | -3 | Neutral |
| NextEra Energy NEE | -4 | Neutral |
| Xcel Energy XEL | -5 | Neutral |
| American International Group AIG | -5 | Neutral |
| Truist Financial TFC | -5 | Neutral |
| Digital Realty Trust DLR | -6 | Neutral |
| Allstate Corp. ALL | -7 | Neutral |
| S&P Global SPGI | -8 | Neutral |
| American Water Works AWK | -9 | Neutral |
| Goldman Sachs Group GS | -10 | Neutral |
| Citigroup Inc. C | -11 | Neutral |
| Moody's Corp. MCO | -13 | Neutral |
| Morgan Stanley MS | -13 | Neutral |
| MetLife Inc. MET | -13 | Neutral |
| Southern Company SO | -15 | Neutral |
| BlackRock Inc. BLK | -15 | Neutral |
| Equinix Inc. EQIX | -16 | Neutral |
| American Electric Power AEP | -18 | Neutral |
| Crown Castle Inc. CCI | -18 | Neutral |
| American Tower Corp. AMT | -39 | Neutral |